The genetics of attention-deficit/hyperactivity disorder

References

• Coghill D, Nigg J, Rothenberger A, Sonuga-Barke E, Tannock R. Whither causal models in the neuroscience of ADHD? Dev. Sci.8(2), 105–114 (2005).
   PubMed Web of Science ®Google Scholar
• Mick E, Faraone SV. Genetics of attention deficit hyperactivity disorder. Child Adolesc. Psychiatr. Clin. N. Am.17(2), 261–284, vii–viii (2008).
   PubMed Web of Science ®Google Scholar
• Waldman ID, Gizer IR. The genetics of attention deficit hyperactivity disorder. Clin. Psychol. Rev.26(4), 396–432 (2006).
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Keenan K et al. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder. Patterns of comorbidity in probands and relatives psychiatrically and pediatrically referred samples. Arch. Gen. Psychiatry49(9), 728–738 (1992).
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Keenan K, Knee D, Tsuang MT. Family-genetic and psychosocial risk factors in DSM-III attention deficit disorder. J. Am. Acad. Child Adolesc. Psychiatry29(4), 526–533 (1990).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Chen WJ, Milberger S, Warburton R, Tsuang MT. Genetic heterogeneity in Attention-deficit/hyperactivity disorder (ADHD): gender, psychiatric comorbidity, and maternal ADHD. J. Abnorm. Psychol.104(2), 334–345 (1995).
   PubMed Web of Science ®Google Scholar
• Biederman J, Faraone SV, Mick E et al. High risk for attention deficit hyperactivity disorder among children of parents with childhood onset of the disorder: a pilot study. Am. J. Psychiatry152(3), 431–435 (1995).
   PubMed Web of Science ®Google Scholar
• Kessler RC, Adler L, Barkley R et al. The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am. J. Psychiatry163(4), 716–723 (2006).
   PubMed Web of Science ®Google Scholar
• Smalley SL, McGough JJ, Del’Homme M et al. Familial clustering of symptoms and disruptive behaviors in multiplex families with attention-deficit/hyperactivity disorder. J. Am. Acad. Child Adolesc. Psychiatry39(9), 1135–1143 (2000).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J. Do attention deficit hyperactivity disorder and major depression share familial risk factors? J. Nerv. Ment. Dis.185(9), 533–541 (1997).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Biederman J, Jetton JG, Tsuang MT. Attention deficit disorder and conduct disorder: longitudinal evidence for a familial subtype. Psychol. Med.27(2), 291–300 (1997).
   PubMed Web of Science ®Google Scholar
• Waschbusch DA. A meta-analytic examination of comorbid hyperactive–impulsive–attention problems and conduct problems. Psychol. Bull.128(1), 118–150 (2002).
   PubMed Web of Science ®Google Scholar
• Cantwell DP. Genetics of hyperactivity. J. Child Psychol. Psychiatry16, 261–264 (1975).
   PubMed Web of Science ®Google Scholar
• Morrison JR, Stewart MA. The psychiatric status of the legal families of adopted hyperactive children. Arch. Gen. Psychiatry28, 888–891 (1973).
   PubMed Web of Science ®Google Scholar
• Sprich S, Biederman J, Crawford MH, Mundy E, Faraone SV. Adoptive and biological families of children and adolescents with ADHD. J. Am. Acad. Child Adolesc. Psychiatry39(11), 1432–1437 (2000).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Perlis RH, Doyle AE et al. Molecular genetics of attention-deficit/hyperactivity disorder. Biol. Psychiatry57(11), 1313–1323 (2005).
   PubMed Web of Science ®Google Scholar
• Thapar A, Langley K, O’Donovan M, Owen M. Refining the attention deficit hyperactivity disorder phenotype for molecular genetic studies. Mol. Psychiatry11(8), 714–720 (2006).
   PubMed Web of Science ®Google Scholar
• Schimmelmann BG, Friedel S, Christiansen H, Dempfle A, Hinney A, Hebebrand J. Genetic findings in attention-deficit and hyperactivity disorder (ADHD). Z. Kinder Jugendpsychiatr. Psychother.34(6), 425–433 (2006).
   PubMedGoogle Scholar
• Ogdie MN, MacPhie IL, Minassian SL et al. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am. J. Hum. Genet.72(5), 1268–1279 (2003).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Doyle AE, Lasky-Su J et al. Linkage analysis of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1387–1391 (2008).
   PubMedGoogle Scholar
• Ogdie MN, Fisher SE, Yang M et al. Attention deficit hyperactivity disorder: fine mapping supports linkage to 5p13, 6q12, 16p13, and 17p11. Am. J. Hum. Genet.75(4), 661–668 (2004).
   PubMedGoogle Scholar
• Bakker SC, van der Meulen EM, Buitelaar JK et al. A whole-genome scan in 164 Dutch sib pairs with attention-deficit/hyperactivity disorder: suggestive evidence for linkage on chromosomes 7p and 15q. Am. J. Hum. Genet.72(5), 1251–1260 (2003).
   PubMed Web of Science ®Google Scholar
• Hebebrand J, Dempfle A, Saar K et al. A genome-wide scan for attention-deficit/hyperactivity disorder in 155 German sib-pairs. Mol. Psychiatry11(2), 196–205 (2006).
   PubMedGoogle Scholar
• Asherson P, Zhou K, Anney RJ et al. A high-density SNP linkage scan with 142 combined subtype ADHD sib pairs identifies linkage regions on chromosomes 9 and 16. Mol. Psychiatry13(5), 514–521 (2008).
   PubMed Web of Science ®Google Scholar
• Arcos-Burgos M, Castellanos FX, Pineda D et al. Attention-deficit/hyperactivity disorder in a population isolate: linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11. Am. J. Hum. Genet.75(6), 998–1014 (2004).
   PubMed Web of Science ®Google Scholar
• Romanos M, Freitag C, Jacob C et al. Genome-wide linkage analysis of ADHD using high-density SNP arrays: novel loci at 5q13.1 and 14q12. Mol. Psychiatry13(5), 522–530 (2008).
   PubMedGoogle Scholar
• Zhou K, Dempfle A, Arcos-Burgos M et al. Meta-analysis of genome-wide linkage scans of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1392–1398 (2008).
   PubMed Web of Science ®Google Scholar
• Uhl GR, Drgon T, Liu QR et al. Genome-wide association for methamphetamine dependence: convergent results from 2 samples. Arch. Gen. Psychiatry65(3), 345–355 (2008).
   PubMed Web of Science ®Google Scholar
• Ogdie MN, Bakker SC, Fisher SE et al. Pooled genome-wide linkage data on 424 ADHD ASPs suggests genetic heterogeneity and a common risk locus at 5p13. Mol. Psychiatry11(1), 5–8 (2006).
   PubMed Web of Science ®Google Scholar
• Friedel S, Saar K, Sauer S et al. Association and linkage of allelic variants of the dopamine transporter gene in ADHD. Mol. Psychiatry12(10), 923–933 (2007).
   PubMedGoogle Scholar
• Doyle AE, Ferreira MA, Sklar PB et al. Multivariate genomewide linkage scan of neurocognitive traits and ADHD symptoms: Suggestive linkage to 3q13. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1399–1411 (2008).
   PubMedGoogle Scholar
• Rommelse NN, Arias-Vasquez A, Altink ME et al. Neuropsychological endophenotype approach to genome-wide linkage analysis identifies susceptibility loci for ADHD on 2q21.1 and 13q12.11. Am. J.Hum. Genet.83(1), 99–105 (2008).
   PubMed Web of Science ®Google Scholar
• Bakker SC, van der Meulen EM, Oteman N et al. DAT1, DRD4, and DRD5 polymorphisms are not associated with ADHD in Dutch families. Am. J. Med. Genet. B Neuropsychiatr. Genet.132(1), 50–52 (2005).
   Google Scholar
• Ogdie MN, MacPhie IL, Minassian SL et al. A genomewide scan for attention-deficit/hyperactivity disorder in an extended sample: suggestive linkage on 17p11. Am. J. Hum. Genet.72(5), 1268–1279 (2003).
   PubMed Web of Science ®Google Scholar
• Smalley SL, Kustanovich V, Minassian SL et al. Genetic linkage of attention-deficit/hyperactivity disorder on chromosome 16p13, in a region implicated in autism. Am. J. Hum. Genet.71(4), 959–963 (2002).
   PubMed Web of Science ®Google Scholar
• Gayan J, Willcutt EG, Fisher SE et al. Bivariate linkage scan for reading disability and attention-deficit/hyperactivity disorder localizes pleiotropic loci. J. Child Psychol. Psychiatry46(10), 1045–1056 (2005).
   PubMed Web of Science ®Google Scholar
• Loo SK, Fisher SE, Francks C et al. Genome-wide scan of reading ability in affected sibling pairs with attention-deficit/hyperactivity disorder: unique and shared genetic effects. Mol. Psychiatry9(5), 485–493 (2004).
   PubMed Web of Science ®Google Scholar
• Zhou K, Asherson P, Sham P et al. Linkage to chromosome 1p36 for attention-deficit/hyperactivity disorder traits in school and home settings. Biol. Psychiatry64(7), 571–576 (2008).
   PubMedGoogle Scholar
• Jain M, Palacio LG, Castellanos FX et al. Attention-deficit/hyperactivity disorder and comorbid disruptive behavior disorders: evidence of pleiotropy and new susceptibility loci. Biol. Psychiatry61(12), 1329–1339 (2007).
   PubMedGoogle Scholar
• Neale BM, Lasky-Su J, Anney R et al. Genome-wide association scan of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1337–1344 (2008).
   PubMed Web of Science ®Google Scholar
• Lasky-Su J, Neale BM, Franke B et al. Genome-wide association scan of quantitative traits for attention deficit hyperactivity disorder identifies novel associations and confirms candidate gene associations. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1345–1354 (2008).
   PubMed Web of Science ®Google Scholar
• Lasky-Su J, Anney RJ, Neale BM et al. Genome-wide association scan of the time to onset of attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1355–1358 (2008).
   PubMedGoogle Scholar
• Oades RD, Lasky-Su J, Christiansen H et al. The influence of serotonin- and other genes on impulsive behavioral aggression and cognitive impulsivity in children with attention-deficit/hyperactivity disorder (ADHD): Findings from a family-based association test (FBAT) analysis. Behav. Brain Funct.4, 48 (2008).
   PubMedGoogle Scholar
• Sonuga-Barke EJ, Brookes KJ, Buitelaar J et al. Intelligence in DSM-IV combined type attention-deficit/hyperactivity disorder is not predicted by either dopamine receptor/transporter genes or other previously identified risk alleles for attention-deficit/hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147(3), 316–319 (2008).
   PubMedGoogle Scholar
• Brookes K, Xu X, Chen W et al. The analysis of 51 genes in DSM-IV combined type attention deficit hyperactivity disorder: association signals in DRD4, DAT1 and 16 other genes. Mol. Psychiatry11(10), 934–953 (2006).
   PubMed Web of Science ®Google Scholar
• Guan L, Wang B, Chen Y et al. A high-density single-nucleotide polymorphism screen of 23 candidate genes in attention deficit hyperactivity disorder: suggesting multiple susceptibility genes among Chinese Han population. Mol. Psychiatry14(4), 546–554 (2008).
   PubMed Web of Science ®Google Scholar
• Faraone SV, Doyle AE, Mick E, Biederman J. Meta-analysis of the association between the 7-repeat allele of the dopamine D(4) receptor gene and attention deficit hyperactivity disorder. Am. J. Psychiatry158(7), 1052–1057 (2001).
   PubMed Web of Science ®Google Scholar
• Li D, Sham PC, Owen MJ, He L. Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum. Mol. Genet.15(14), 2276–2284 (2006).
   PubMed Web of Science ®Google Scholar
• Bhaduri N, Das M, Sinha S et al. Association of dopamine D4 receptor (DRD4) polymorphisms with attention deficit hyperactivity disorder in Indian population. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(1), 61–66 (2006).
   Google Scholar
• Ballon N, Leroy S, Roy C et al. Polymorphisms TaqI A of the DRD2, BalI of the DRD3, exon III repeat of the DRD4, and 3´ UTR VNTR of the DAT: association with childhood ADHD in male African–Caribbean cocaine dependents? Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(8), 1034–1041 (2007).
   PubMed Web of Science ®Google Scholar
• Cheuk DK, Li SY, Wong V. Exon 3 polymorphisms of dopamine D4 receptor (DRD4) gene and attention deficit hyperactivity disorder in Chinese children. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(8), 907–911 (2006).
   Google Scholar
• Guan LL, Wang YF, Li J, Wang B, Yang L, Qian QJ . [Association analysis of dopamine D4 receptor gene polymorphism and attention deficit hyperactivity disorder with/without disruptive behavior disorder.] Beijing Da Xue Xue Bao39(3), 233–236 (2007).
   PubMedGoogle Scholar
• Yang JW, Jang WS, Hong SD et al. A case–control association study of the polymorphism at the promoter region of the DRD4 gene in Korean boys with attention deficit-hyperactivity disorder: evidence of association with the -521 C/T SNP. Prog. Neuropsychopharmacol. Biol. Psychiatry32(1), 243–248 (2008).
   PubMedGoogle Scholar
• Asghari V, Sanyal S, Buchwaldt S, Paterson A, Jovanovic V, Van Tol HH. Modulation of intracellular cyclic AMP levels by different human dopamine D4 receptor variants. J. Neurochem.65, 1157–1165 (1995).
   PubMed Web of Science ®Google Scholar
• Langley K, Marshall L, Van den BM et al. Association of the dopamine D4 receptor gene 7-repeat allele with neuropsychological test performance of children with ADHD. Am. J. Psychiatry161(1), 133–138 (2004).
   PubMed Web of Science ®Google Scholar
• Swanson J, Oosterlaan J, Murias M et al. Attention deficit/hyperactivity disorder children with a 7-repeat allele of the dopamine receptor D4 gene have extreme behavior but normal performance on critical neuropsychological tests of attention. Proc. Natl. Acad. Sci. USA97(9), 4754–4759 (2000).
   PubMed Web of Science ®Google Scholar
• Manor I, Tyano S, Eisenberg J, Bachner-Melman R, Kotler M, Ebstein RP. The short DRD4 repeats confer risk to attention deficit hyperactivity disorder in a family-based design and impair performance on a continuous performance test (TOVA). Mol. Psychiatry7(7), 790–794 (2002).
   PubMed Web of Science ®Google Scholar
• Barkley RA, Smith KM, Fischer M, Navia B. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(5), 487–498 (2006).
   Web of Science ®Google Scholar
• Loo SK, Rich EC, Ishii J et al. Cognitive functioning in affected sibling pairs with ADHD: familial clustering and dopamine genes. J. Child Psychol. Psychiatry49(9), 950–957 (2008).
   PubMedGoogle Scholar
• Johnson KA, Kelly SP, Robertson IH et al. Absence of the 7-repeat variant of the DRD4 VNTR is associated with drifting sustained attention in children with ADHD but not in controls. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(6), 927–937 (2008).
   PubMed Web of Science ®Google Scholar
• Kieling C, Genro JP, Hutz MH, Rohde LA. The -1021 C/T DBH polymorphism is associated with neuropsychological performance among children and adolescents with ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(4), 485–490 (2008).
   PubMedGoogle Scholar
• Rommelse NN. Endophenotypes in the genetic research of ADHD over the last decade: have they lived up to their expectations? Expert Rev. Neurother.8(10), 1425–1429 (2008).
   PubMedGoogle Scholar
• Doyle AE, Faraone SV, Seidman LJ et al. Are endophenotypes based on measures of executive functions useful for molecular genetic studies of ADHD? J. Child Psychol. Psychiatry46(7), 774–803 (2005).
   PubMed Web of Science ®Google Scholar
• Groot AS, de Sonneville LM, Stins JF, Boomsma DI. Familial influences on sustained attention and inhibition in preschoolers. J. Child Psychol. Psychiatry45(2), 306–314 (2004).
   PubMed Web of Science ®Google Scholar
• Stins JF, van Baal GC, Polderman TJ, Verhulst FC, Boomsma DI. Heritability of Stroop and flanker performance in 12-year old children. BMC Neurosci.5, 49 (2004).
   PubMed Web of Science ®Google Scholar
• Anokhin AP, Heath AC, Ralano A. Genetic influences on frontal brain function: WCST performance in twins. Neuroreport14(15), 1975–1978 (2003).
   PubMed Web of Science ®Google Scholar
• Fan J, Wu Y, Fossella JA, Posner MI. Assessing the heritability of attentional networks. BMC Neurosci.2(1), 14 (2001).
   PubMed Web of Science ®Google Scholar
• Durston S, Fossella JA, Casey BJ et al. Differential effects of DRD4 and DAT1 genotype on fronto–striatal gray matter volumes in a sample of subjects with attention deficit hyperactivity disorder, their unaffected siblings, and controls. Mol. Psychiatry10(7), 678–685 (2005).
   PubMed Web of Science ®Google Scholar
• Monuteaux MC, Seidman LJ, Faraone SV et al. A preliminary study of dopamine D4 receptor genotype and structural brain alterations in adults with ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1436–1441 (2008).
   PubMed Web of Science ®Google Scholar
• Shaw P, Gornick M, Lerch J et al. Polymorphisms of the dopamine D4 receptor, clinical outcome, and cortical structure in attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry64(8), 921–931 (2007).
   PubMed Web of Science ®Google Scholar
• El Faddagh M, Laucht M, Maras A, Vohringer L, Schmidt MH. Association of dopamine D4 receptor (DRD4) gene with attention-deficit/hyperactivity disorder (ADHD) in a high-risk community sample: a longitudinal study from birth to 11 years of age. J. Neural Transm.111(7), 883–889 (2004).
   PubMedGoogle Scholar
• Holmes J, Payton A, Barrett J et al. Association of DRD4 in children with ADHD and comorbid conduct problems. Am. J. Med. Genet.114(2), 150–153 (2002).
   PubMedGoogle Scholar
• Carrasco X, Rothhammer P, Moraga M et al. Genotypic interaction between DRD4 and DAT1 loci is a high risk factor for attention-deficit/hyperactivity disorder in Chilean families. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(1), 51–54 (2006).
   Google Scholar
• Henriquez BH, Henriquez HM, Carrasco CX et al. Combination of DRD4 and DAT1 genotypes is an important risk factor for attention deficit disorder with hyperactivity families living in Santiago, Chile. Rev. Med. Chil.136(6), 719–724 (2008).
   PubMedGoogle Scholar
• Qian Q, Wang Y, Li J et al. Evaluation of potential gene-gene interactions for attention deficit hyperactivity disorder in the Han Chinese population. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(2), 200–206 (2007).
   Google Scholar
• Lowe N, Kirley A, Hawi Z et al. Joint analysis of the DRD5 marker concludes association with attention-deficit/hyperactivity disorder confined to the predominantly inattentive and combined subtypes. Am. J. Hum. Genet.74(2), 348–356 (2004).
   PubMed Web of Science ®Google Scholar
• Mill J, Xu X, Ronald A et al. Quantitative trait locus analysis of candidate gene alleles associated with attention deficit hyperactivity disorder (ADHD) in five genes: DRD4, DAT1, DRD5, SNAP-25, and 5HT1B. Am. J. Med. Genet. B Neuropsychiatr. Genet.133(1), 68–73 (2005).
   Web of Science ®Google Scholar
• Misener VL, Luca P, Azeke O et al. Linkage of the dopamine receptor D1 gene to attention-deficit/hyperactivity disorder. Mol. Psychiatry9(5), 500–509 (2004).
   PubMed Web of Science ®Google Scholar
• VanNess SH, Owens MJ, Kilts CD. The variable number of tandem repeats element in DAT1 regulates in vitro dopamine transporter density. BMC Genet.6, 55 (2005).
   PubMed Web of Science ®Google Scholar
• Banoei MM, Majidizadeh T, Shirazi E et al. No association between the DAT1 ten-repeat allele and ADHD in the Iranian population. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(1), 110–111 (2008).
   PubMedGoogle Scholar
• Das M, Mukhopadhyay K. DAT1 3´-UTR 9R allele: preferential transmission in Indian children with attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(6), 826–829 (2007).
   Google Scholar
• Genro JP, Polanczyk GV, Zeni C et al. A common haplotype at the dopamine transporter gene 5´ region is associated with attention-deficit/hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1568–1575 (2008).
   PubMedGoogle Scholar
• Genro JP, Zeni C, Polanczyk GV, Roman T, Rohde LA, Hutz MH. A promoter polymorphism (-839 C > T) at the dopamine transporter gene is associated with attention deficit/hyperactivity disorder in Brazilian children. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(2), 215–219 (2007).
   Google Scholar
• Brookes KJ, Xu X, Anney R et al. Association of ADHD with genetic variants in the 5´-region of the dopamine transporter gene: evidence for allelic heterogeneity. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1519–1523 (2008).
   PubMedGoogle Scholar
• Xu X, Mill J, Sun B et al. Association study of promoter polymorphisms at the dopamine transporter gene in attention deficit hyperactivity disorder. BMC Psychiatry9, 3 (2009).
   PubMed Web of Science ®Google Scholar
• Biederman J, Kim JW, Doyle AE et al. Sexually dimorphic effects of four genes (COMT, SLC6A2, MAOA, SLC6A4) in genetic associations of ADHD: a preliminary study. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1511–1518 (2008).
   PubMed Web of Science ®Google Scholar
• Hawi Z, Segurado R, Conroy J et al. Preferential transmission of paternal alleles at risk genes in attention-deficit/hyperactivity disorder. Am. J. Hum. Genet.77(6), 958–965 (2005).
   PubMedGoogle Scholar
• Hawi Z, Kent L, Hill M et al. ADHD and DAT1: Further evidence of paternal over-transmission of risk alleles and haplotype. Am. J. Med. Genet. B Neuropsychiatr. Genet. (2009) (Epub ahead of print).
   Google Scholar
• Anney RJ, Hawi Z, Sheehan K et al. Parent of origin effects in attention/deficit hyperactivity disorder (ADHD): analysis of data from the international multicenter ADHD genetics (IMAGE) program. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1495–1500 (2008).
   PubMedGoogle Scholar
• Asherson P, Brookes K, Franke B et al. Confirmation that a specific haplotype of the dopamine transporter gene is associated with combined-type ADHD. Am. J. Psychiatry164(4), 674–677 (2007).
   PubMed Web of Science ®Google Scholar
• Brookes KJ, Mill J, Guindalini C et al. A common haplotype of the dopamine transporter gene associated with attention-deficit/hyperactivity disorder and interacting with maternal use of alcohol during pregnancy. Arch. Gen. Psychiatry63(1), 74–81 (2006).
   PubMed Web of Science ®Google Scholar
• Zhou K, Chen W, Buitelaar J et al. Genetic heterogeneity in ADHD: DAT1 gene only affects probands without CD. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1481–1487 (2008).
   PubMedGoogle Scholar
• Karama S, Grizenko N, Sonuga-Barke E et al. Dopamine transporter 3’UTR VNTR genotype is a marker of performance on executive function tasks in children with ADHD. BMC Psychiatry8, 45 (2008).
   PubMed Web of Science ®Google Scholar
• Bellgrove MA, Barry E, Johnson KA et al. Spatial attentional bias as a marker of genetic risk, symptom severity, and stimulant response in ADHD. Neuropsychopharmacology33(10), 2536–2545 (2008).
   PubMed Web of Science ®Google Scholar
• Rommelse NN, Altink ME, Arias-Vasquez A et al. A review and analysis of the relationship between neuropsychological measures and DAT1 in ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1536–1546 (2008).
   PubMed Web of Science ®Google Scholar
• Ribases M, Ramos-Quiroga JA, Hervas A et al. Exploration of 19 serotoninergic candidate genes in adults and children with attention-deficit/hyperactivity disorder identifies association for 5HT2A, DDC and MAOB. Mol. Psychiatry14(1), 71–85 (2007).
   PubMedGoogle Scholar
• Bellgrove MA, Hawi Z, Lowe N, Kirley A, Robertson IH, Gill M. DRD4 gene variants and sustained attention in attention deficit hyperactivity disorder (ADHD): effects of associated alleles at the VNTR and -521 SNP. Am. J. Med. Genet. B Neuropsychiatr. Genet.136(1), 81–86 (2005).
   Google Scholar
• Bellgrove MA, Hawi Z, Gill M, Robertson IH. The cognitive genetics of attention deficit hyperactivity disorder (ADHD): sustained attention as a candidate phenotype. Cortex42(6), 838–845 (2006).
   PubMed Web of Science ®Google Scholar
• Barkley RA, Smith KM, Fischer M, Navia B. An examination of the behavioral and neuropsychological correlates of three ADHD candidate gene polymorphisms (DRD4 7+, DBH TaqI A2, and DAT1 40 bp VNTR) in hyperactive and normal children followed to adulthood. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(5), 487–498 (2006).
   Web of Science ®Google Scholar
• Cheuk DK, Wong V. Meta-analysis of association between a catechol- O-methyltransferase gene polymorphism and attention deficit hyperactivity disorder. Behav. Genet.36(5), 651–659 (2006).
   PubMedGoogle Scholar
• Halleland H, Lundervold AJ, Halmoy A, Haavik J, Johansson S. Association between catechol O-methyltransferase (COMT) haplotypes and severity of hyperactivity symptoms in adults. Am. J. Med. Genet. B Neuropsychiatr. Genet.150B(3), 403–410 (2009).
   PubMed Web of Science ®Google Scholar
• Retz W, Rosler M, Kissling C et al. Norepinephrine transporter and catecholamine- O-methyltransferase gene variants and attention-deficit/hyperactivity disorder symptoms in adults. J. Neural Transm.115(2), 323–329 (2008).
   PubMedGoogle Scholar
• Thapar A, Langley K, Fowler T et al. Catechol O-methyltransferase gene variant and birth weight predict early-onset antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry62(11), 1275–1278 (2005).
   PubMed Web of Science ®Google Scholar
• Caspi A, Langley K, Milne B et al. A replicated molecular genetic basis for subtyping antisocial behavior in children with attention-deficit/hyperactivity disorder. Arch. Gen. Psychiatry65(2), 203–210 (2008).
   PubMed Web of Science ®Google Scholar
• Das M, Bhowmik AD, Sinha S et al. MAOA promoter polymorphism and attention deficit hyperactivity disorder (ADHD) in Indian children. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(6), 637–642 (2006).
   Google Scholar
• Rommelse NN, Altink ME, Arias-Vasquez A et al. Differential association between MAOA, ADHD and neuropsychological functioning in boys and girls. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1524–1530 (2008).
   PubMed Web of Science ®Google Scholar
• Xu X, Brookes K, Chen CK, Huang YS, Wu YY, Asherson P. Association study between the monoamine oxidase A gene and attention deficit hyperactivity disorder in Taiwanese samples. BMC Psychiatry7, 10 (2007).
   PubMedGoogle Scholar
• Lung FW, Yang P, Cheng TS, Kao WT. No allele variation of the MAOA gene promoter in male Chinese subjects with attention deficit hyperactivity disorder. Neuropsychobiology54(3), 147–151 (2006).
   PubMedGoogle Scholar
• Li J, Kang C, Zhang H et al. Monoamine oxidase A gene polymorphism predicts adolescent outcome of attention-deficit/hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(4), 430–433 (2007).
   Google Scholar
• Li J, Wang Y, Hu S et al. The monoamine oxidase B gene exhibits significant association to ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet.147(3), 370–374 (2008).
   PubMedGoogle Scholar
• Comings DE, Gade-Andavolu R, Gonzalez N et al. Comparison of the role of dopamine, serotonin, and noradrenaline genes in ADHD, ODD and conduct disorder: multivariate regression analysis of 20 genes. Clin. Genet.57(3), 178–196 (2000).
   PubMed Web of Science ®Google Scholar
• Barr CL, Kroft J, Feng Y et al. The norepinephrine transporter gene and attention-deficit hyperactivity disorder. Am. J. Med. Genet.114(3), 255–259 (2002).
   PubMed Web of Science ®Google Scholar
• Cho SC, Kim JW, Kim BN et al. No evidence of an association between norepinephrine transporter gene polymorphisms and attention deficit hyperactivity disorder: a family-based and case-control association study in a Korean sample. Neuropsychobiology57(3), 131–138 (2008).
   PubMedGoogle Scholar
• McEvoy B, Hawi Z, Fitzgerald M, Gill M. No evidence of linkage or association between the norepinephrine transporter (NET) gene polymorphisms and ADHD in the Irish population. Am. J. Med. Genet.114(6), 665–666 (2002).
   PubMedGoogle Scholar
• Bobb AJ, Addington AM, Sidransky E et al. Support for association between ADHD and two candidate genes: NET1 and DRD1. Am. J. Med. Genet. B Neuropsychiatr. Genet.134B(1), 67–72 (2005).
   PubMedGoogle Scholar
• Brookes KJ, Knight J, Xu X, Asherson P. DNA pooling analysis of ADHD and genes regulating vesicle release of neurotransmitters. Am. J. Med. Genet. B Neuropsychiatr. Genet.139(1), 33–37 (2005).
   Google Scholar
• Kim CH, Hahn MK, Joung Y et al. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc. Natl. Acad. Sci. USA103(50), 19164–19169 (2006).
   PubMed Web of Science ®Google Scholar
• Xu X, Knight J, Brookes K et al. DNA pooling analysis of 21 norepinephrine transporter gene SNPs with attention deficit hyperactivity disorder: no evidence for association. Am. J. Med. Genet. B Neuropsychiatr. Genet.134(1), 115–118 (2005).
   Google Scholar
• Kim CH, Waldman ID, Blakely RD, Kim KS. Functional gene variation in the human norepinephrine transporter: association with attention deficit hyperactivity disorder. Ann. NY Acad. Sci.1129, 256–260 (2008).
   PubMed Web of Science ®Google Scholar
• Kim JW, Biederman J, McGrath CL et al. Further evidence of association between two NET single-nucleotide polymorphisms with ADHD. Mol. Psychiatry13(6), 624–630 (2008).
   PubMedGoogle Scholar
• Cho SC, Kim JW, Kim BN et al. Possible association of the α-2A-adrenergic receptor gene with response time variability in attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(6), 957–963 (2008).
   PubMedGoogle Scholar
• Wang B, Wang Y, Zhou R et al. Possible association of the α-2A adrenergic receptor gene (ADRA2A) with symptoms of attention-deficit/hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(2), 130–134 (2006).
   Google Scholar
• Deupree JD, Smith SD, Kratochvil CJ et al. Possible involvement of α-2A adrenergic receptors in attention deficit hyperactivity disorder: radioligand binding and polymorphism studies. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(8), 877–884 (2006).
   Google Scholar
• Roman T, Polanczyk GV, Zeni C, Genro JP, Rohde LA, Hutz MH. Further evidence of the involvement of α-2A-adrenergic receptor gene (ADRA2A) in inattentive dimensional scores of attention-deficit/hyperactivity disorder. Mol. Psychiatry11(1), 8–10 (2006).
   PubMedGoogle Scholar
• Schmitz M, Denardin D, Silva TL et al. Association between α-2A-adrenergic receptor gene and ADHD inattentive type. Biol. Psychiatry60(10), 1028–1033 (2006).
   PubMed Web of Science ®Google Scholar
• Waldman ID, Nigg JT, Gizer IR, Park L, Rappley MD, Friderici K. The adrenergic receptor α-2A gene (ADRA2A) and neuropsychological executive functions as putative endophenotypes for childhood ADHD. Cogn. Affect. Behav. Neurosci.6(1), 18–30 (2006).
   PubMed Web of Science ®Google Scholar
• Cho SC, Kim JW, Kim BN et al. Association between the α-2C-adrenergic receptor gene and attention deficit hyperactivity disorder in a Korean sample. Neurosci. Lett.446(2–3), 108–111 (2008).
   PubMedGoogle Scholar
• Kopeckova M, Paclt I, Petrasek J, Pacltova D, Malikova M, Zagatova V. Some ADHD polymorphisms (in genes DAT1, DRD2, DRD3, DBH, 5-HTT) in case–control study of 100 subjects 6–10 age. Neuro. Endocrinol. Lett.29(2), 246–251 (2008).
   PubMedGoogle Scholar
• Li J, Wang Y, Zhou R et al. Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(1), 14–19 (2007).
   Google Scholar
• Retz W, Freitag CM, Retz-Junginger P et al. A functional serotonin transporter promoter gene polymorphism increases ADHD symptoms in delinquents: interaction with adverse childhood environment. Psychiatry Res.158(2), 123–131 (2008).
   PubMed Web of Science ®Google Scholar
• Grevet EH, Marques FZ, Salgado CA et al. Serotonin transporter gene polymorphism and the phenotypic heterogeneity of adult ADHD. J. Neural Transm.114(12), 1631–1636 (2007).
   PubMedGoogle Scholar
• Wigg KG, Takhar A, Ickowicz A et al. Gene for the serotonin transporter and ADHD: no association with two functional polymorphisms. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(6), 566–570 (2006).
   Google Scholar
• Xu X, Aysimi E, Anney R et al. No association between two polymorphisms of the serotonin transporter gene and combined type attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(7), 1306–1309 (2008).
   PubMed Web of Science ®Google Scholar
• Banerjee E, Sinha S, Chatterjee A, Gangopadhyay PK, Singh M, Nandagopal K. A family-based study of Indian subjects from Kolkata reveals allelic association of the serotonin transporter intron-2 (STin2) polymorphism and attention-deficit-hyperactivity disorder (ADHD). Am. J. Med. Genet. B Neuropsychiatr. Genet.141(4), 361–366 (2006).
   Google Scholar
• Quist JF, Barr CL, Schachar R et al. The serotonin 5-HT1B receptor gene and attention deficit hyperactivity disorder. Mol. Psychiatry8(1), 98–102 (2003).
   PubMed Web of Science ®Google Scholar
• Hawi Z, Dring M, Kirley A et al. Serotonergic system and attention deficit hyperactivity disorder (ADHD): a potential susceptibility locus at the 5-HT(1B) receptor gene in 273 nuclear families from a multi-centre sample. Mol. Psychiatry7(7), 718–725 (2002).
   PubMed Web of Science ®Google Scholar
• Ickowicz A, Feng Y, Wigg K et al. The serotonin receptor HTR1B: gene polymorphisms in attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(1), 121–125 (2007).
   Google Scholar
• Guimaraes AP, Zeni C, Polanczyk GV et al. Serotonin genes and attention deficit/hyperactivity disorder in a Brazilian sample: preferential transmission of the HTR2A 452His allele to affected boys. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(1), 69–73 (2007).
   Google Scholar
• Li J, Wang Y, Zhou R et al. No association of attention-deficit/hyperactivity disorder with genes of the serotonergic pathway in Han Chinese subjects. Neurosci. Lett.403(1–2), 172–175 (2006).
   PubMedGoogle Scholar
• Li J, Wang Y, Zhou RL, Yang L, Zhang HB, Wang B. Association between serotonin 1D gene polymorphisms and attention deficit hyperactivity disorder comorbid or not comorbid learning disorder. Beijing Da Xue Xue Bao39(5), 535–538 (2007).
   PubMedGoogle Scholar
• Li J, Zhang X, Wang Y et al. The serotonin 5-HT1D receptor gene and attention-deficit/hyperactivity disorder in Chinese Han subjects. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(8), 874–876 (2006).
   Google Scholar
• Li J, Wang YF, Zhou RL, Yang L, Zhan HB, Wang B. [Association between serotonin 2C gene polymorphisms and attention deficit hyperactivity disorder in children with or without comorbidity of disruptive behavior disorder.] Zhonghua Er Ke Za Zhi45(5), 374–377 (2007).
   PubMedGoogle Scholar
• Li J, Wang Y, Zhou R et al. Association of attention-deficit/hyperactivity disorder with serotonin 4 receptor gene polymorphisms in Han Chinese subjects. Neurosci. Lett.401(1–2), 6–9 (2006).
   PubMedGoogle Scholar
• Li J, Kang C, Wang Y et al. Contribution of 5-HT2A receptor gene -1438A>G polymorphism to outcome of attention-deficit/hyperactivity disorder in adolescents. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(5), 473–476 (2006).
   Google Scholar
• Li J, Wang YF, Zhou RL, Yang L, Zhang HB, Wang B. Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder with or without learning disorder. Zhonghua Yi Xue Za Zhi83(24), 2114–2118 (2003).
   PubMedGoogle Scholar
• Li J, Wang Y, Zhou R et al. Association between tryptophan hydroxylase gene polymorphisms and attention deficit hyperactivity disorder in Chinese Han population. Am. J. Med. Genet. B Neuropsychiatr. Genet.141(2), 126–129 (2006).
   Google Scholar
• Sheehan K, Lowe N, Kirley A et al. Tryptophan hydroxylase 2 (TPH2) gene variants associated with ADHD. Mol. Psychiatry10(10), 944–949 (2005).
   PubMed Web of Science ®Google Scholar
• Walitza S, Renner TJ, Dempfle A et al. Transmission disequilibrium of polymorphic variants in the tryptophan hydroxylase-2 gene in attention-deficit/hyperactivity disorder. Mol. Psychiatry10(12), 1126–1132 (2005).
   PubMed Web of Science ®Google Scholar
• Choi TK, Lee HS, Kim JW et al. Support for the MnlI polymorphism of SNAP25; a Korean ADHD case–control study. Mol. Psychiatry12(3), 224–226 (2007).
   PubMedGoogle Scholar
• Kim JW, Biederman J, Arbeitman L et al. Investigation of variation in SNAP-25 and ADHD and relationship to co-morbid major depressive disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(6), 781–790 (2007).
   Google Scholar
• Renner TJ, Walitza S, Dempfle A et al. Allelic variants of SNAP25 in a family-based sample of ADHD. J. Neural Transm.115(2), 317–321 (2008).
   PubMedGoogle Scholar
• Comings DE, Gade-Andavolu R, Gonzalez N et al. Multivariate analysis of associations of 42 genes in ADHD, ODD and conduct disorder. Clin. Genet.58(1), 31–40 (2000).
   PubMed Web of Science ®Google Scholar
• Todd RD, Lobos EA, Sun LW, Neuman RJ. Mutational analysis of the nicotinic acetylcholine receptor α 4 subunit gene in attention deficit/hyperactivity disorder: evidence for association of an intronic polymorphism with attention problems. Mol. Psychiatry8(1), 103–108 (2003).
   PubMedGoogle Scholar
• Lee J, Laurin N, Crosbie J et al. Association study of the nicotinic acetylcholine receptor α4 subunit gene, CHRNA4, in attention-deficit hyperactivity disorder. Genes Brain Behav.7(1), 53–60 (2008).
   PubMed Web of Science ®Google Scholar
• Turic D, Langley K, Mills S et al. Follow-up of genetic linkage findings on chromosome 16p13: evidence of association of N-methyl-D aspartate glutamate receptor 2A gene polymorphism with ADHD. Mol. Psychiatry9(2), 169–173 (2004).
   PubMedGoogle Scholar
• Adams J, Crosbie J, Wigg K et al. Glutamate receptor, ionotropic, N-methyl-D-aspartate 2A (GRIN2A) gene as a positional candidate for attention-deficit/hyperactivity disorder in the 16p13 region. Mol. Psychiatry9(5), 494–499 (2004).
   PubMedGoogle Scholar
• Dorval KM, Wigg KG, Crosbie J et al. Association of the glutamate receptor subunit gene GRIN2B with attention-deficit/hyperactivity disorder. Genes Brain Behav.6(5), 444–452 (2007).
   PubMedGoogle Scholar
• Conner AC, Kissling C, Hodges E et al. Neurotrophic factor-related gene polymorphisms and adult attention deficit hyperactivity disorder (ADHD) score in a high-risk male population. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1476–1480 (2008).
   PubMed Web of Science ®Google Scholar
• Ribases M, Hervas A, Ramos-Quiroga JA et al. Association study of 10 genes encoding neurotrophic factors and their receptors in adult and child attention-deficit/hyperactivity disorder. Biol. Psychiatry63(10), 935–945 (2008).
   PubMed Web of Science ®Google Scholar
• Lee J, Laurin N, Crosbie J et al. Association study of the brain-derived neurotropic factor (BDNF) gene in attention deficit hyperactivity disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(8), 976–981 (2007).
   PubMedGoogle Scholar
• Schimmelmann BG, Friedel S, Dempfle A et al. No evidence for preferential transmission of common valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor gene (BDNF) in ADHD. J. Neural Transm.114(4), 523–526 (2007).
   PubMedGoogle Scholar
• Xu X, Mill J, Zhou K, Brookes K, Chen CK, Asherson P. Family-based association study between brain-derived neurotrophic factor gene polymorphisms and attention deficit hyperactivity disorder in UK and Taiwanese samples. Am. J. Med. Genet. B Neuropsychiatr. Genet.144(1), 83–86 (2007).
   Google Scholar
• Syed Z, Dudbridge F, Kent L. An investigation of the neurotrophic factor genes GDNF, NGF, and NT3 in susceptibility to ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(3), 375–378 (2007).
   PubMedGoogle Scholar
• Kent L, Green E, Hawi Z et al. Association of the paternally transmitted copy of common Valine allele of the Val66Met polymorphism of the brain-derived neurotrophic factor (BDNF) gene with susceptibility to ADHD. Mol. Psychiatry10(10), 939–943 (2005).
   PubMed Web of Science ®Google Scholar
• Langley K, Rice F, Van den Bree MB, Thapar A. Maternal smoking during pregnancy as an environmental risk factor for attention deficit hyperactivity disorder behaviour. A review. Minerva Pediatr.57(6), 359–371 (2005).
   PubMedGoogle Scholar
• Bhutta AT, Cleves MA, Casey PH, Cradock MM, Anand KJ. Cognitive and behavioral outcomes of school-aged children who were born preterm: a meta-analysis. JAMA288(6), 728–737 (2002).
   PubMed Web of Science ®Google Scholar
• Nigg JT. What Causes ADHD? Understanding What Goes Wrong and Why. The Guilford Press, NY, USA (2006).
   Google Scholar
• Purcell S. Variance components models for gene–environment interaction in twin analysis. Twin Res.5(6), 554–571 (2002).
   PubMedGoogle Scholar
• Kahn RS, Khoury J, Nichols WC, Lanphear BP. Role of dopamine transporter genotype and maternal prenatal smoking in childhood hyperactive–impulsive, inattentive, and oppositional behaviors. J. Pediatr.143(1), 104–110 (2003).
   PubMed Web of Science ®Google Scholar
• Neuman RJ, Lobos E, Reich W, Henderson CA, Sun LW, Todd RD. Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol. Psychiatry61(12), 1320–1328 (2007).
   PubMedGoogle Scholar
• Langley K, Turic D, Rice F et al. Testing for gene x environment interaction effects in attention deficit hyperactivity disorder and associated antisocial behavior. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(1), 49–53 (2008).
   PubMedGoogle Scholar
• Todd RD, Neuman RJ. Gene–environment interactions in the development of combined type ADHD: evidence for a synapse-based model. Am. J. Med. Genet. B Neuropsychiatr. Genet.144B(8), 971–975 (2007).
   PubMed Web of Science ®Google Scholar
• Sengupta SM, Grizenko N, Schmitz N et al. COMT Val108/158Met gene variant, birth weight, and conduct disorder in children with ADHD. J. Am. Acad. Child Adolesc. Psychiatry45(11), 1363–1369 (2006).
   PubMedGoogle Scholar
• Laucht M, Skowronek MH, Becker K et al. Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Arch. Gen. Psychiatry64(5), 585–590 (2007).
   PubMed Web of Science ®Google Scholar
• Muller DJ, Mandelli L, Serretti A et al. Serotonin transporter gene and adverse life events in adult ADHD. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1461–1469 (2008).
   PubMedGoogle Scholar
• Sonuga-Barke EJ, Lasky-Su J, Neale BM et al. Does parental expressed emotion moderate genetic effects in ADHD? an exploration using a genome wide association scan. Am. J. Med. Genet. B Neuropsychiatr. Genet.147B(8), 1359–1368 (2008).
   PubMedGoogle Scholar
• Waldman ID. Gene–environment interactions reexamined: does mother’s marital stability interact with the dopamine receptor D2 gene in the etiology of childhood attention-deficit/hyperactivity disorder? Dev. Psychopathol.19(4), 1117–1128 (2007).
   PubMed Web of Science ®Google Scholar
• Stringaris AK, Asherson P. Molecular genetics in child psychiatry. In: Biological Psychiatry: Recent Trends and Developments. Banaschewski T, Rohde LA (Eds). Karger, Basel, Switzerland 181–194 (2008).
   Google Scholar
• Lasky-Su J, Biederman J, Laird N et al. Evidence for an association of the dopamine D5 receptor gene on age at onset of attention deficit hyperactivity disorder. Ann. Hum. Genet.71(Pt 5), 648–659 (2007).
   PubMedGoogle Scholar
• Christiansen H, Chen W, Oades RD et al. Co-transmission of conduct problems with attention-deficit/hyperactivity disorder: familial evidence for a distinct disorder. J. Neural Transm.115(2), 163–175 (2008).
   PubMedGoogle Scholar
• Faraone SV. Report from the 4th International Meeting of the Attention Deficit Hyperactivity Disorder Molecular Genetics Network. Am. J. Med. Genet. B Neuropsychiatr. Genet.121(1), 55–59 (2003).
   Google Scholar
• Kuntsi J, Neale BM, Chen W, Faraone SV, Asherson P. The IMAGE project: methodological issues for the molecular genetic analysis of ADHD. Behav. Brain Funct.2, 27 (2006).
   PubMedGoogle Scholar
• Manolio TA, Rodriguez LL, Brooks L et al. New models of collaboration in genome-wide association studies: the Genetic Association Information Network. Nat. Genet.39(9), 1045–1051 (2007).
   PubMed Web of Science ®Google Scholar